Summary
Berkley Gryder is an assistant professor at Case Western Reserve University School of Medicine who blends chemistry, molecular biology, and computer science to probe how cancer cells control gene expression and to develop chemical strategies that disrupt their transcriptional addictions. With a Ph.D. from Georgia Tech and 11 years of research experience including a multi-year postdoc at the National Cancer Institute, he has published in Journal of Medicinal Chemistry, ACS Chemical Biology, and Future Medicinal Chemistry and proposed paradigm-shifting explanations for long-standing conundrums. He builds bespoke high–spatial and temporal-precision tools to interrogate epigenetic mechanisms, often inventing methods when existing tools fall short. His work explicitly targets translational outcomes, aiming to convert mechanistic insights into effective cancer therapies. Based in Wickliffe, Ohio, he brings industrial process engineering experience from Cognis to streamline experimental systems and data pipelines in the lab. An uncommon mix of synthetic chemistry rigor, computational thinking, and molecular biology gives him a knack for reframing problems and uncovering surprising vulnerabilities in cancer cells.
11 years of coding experience
5 years of employment as a software developer
BS, Chemistry, BS, Chemistry at Clemson University
Bob Jones University
Doctor of Philosophy (Ph.D.), Chemistry and Biochemistry, Doctor of Philosophy (Ph.D.), Chemistry and Biochemistry at Georgia Institute of Technology